Tag: companion diagnostics
Ado-trastuzumab emtansine Approved for the Treatment of Early Breast Cancer
In early May 2019, the United States Food and Drug Administration (FDA) approved ado-trastuzumab emtansine (Kadcyla®, Genentech/Roche; T-DM1) for the adjuvant treatment of patients...
AACR 2016: Companion and Complementary Diagnostics
Over the last decade, Targeted Therapies, Personalized and Precision Medicine have become part of our vocabulary, representing a new way of thinking in how...
Companion Diagnostics: Paving the Way for Personalized Medicine
There has been a real revolution in the understanding of molecular biology. This revolution is fueled by the rapid decline in the costs of...
